Clinical Trial Update: Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell. [Phase 4]

View source ↗

Summary

Phase 4 trial exploring aerosolized retinoic acid as a treatment for post-COVID-19 anosmia, evaluating restoration of smell.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-covid-19 Anosmia

Drugs mentioned

• Aerosolized retinoic acid (retinoic acid)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Post COVID-19 Anosmia (Loss of Smell) | Phase 4 | Status: UNKNOWN